Japan, March 26 -- CONFO THERAPEUTICS N V has got intellectual property rights for 'COMPOUNDS FOR TREATMENT OF PAIN, IN PARTICULAR NEUROPATHIC PAIN, AND/OR OTHER DISEASES OR DISORDERS THAT ARE ASSOCIATED WITH AT2R AND/OR AT2R MEDIATED SIGNALING.' Other related details are as follows:

Application Number: JP,2025-023227

Category (FI): A61K31/454,A61K31/496,A61K31/497,A61K31/498,A61K31/4995,A61K31/501,A61K31/506,A61K31/517,A61K31/519,A61K31/5377,A61K31/551,A61P25/02,A61P25/04,C07D235/14,C07D277/82,C07D401/06,C07D401/12,C07D401/14,C07D403/12,C07D403/14,C07D409/14,C07D413/12,C07D417/12,C07D417/14,C07D471/04,108@A,C07D471/04,116,C07D487/04,137,C07D487/04,142,C07D487/04,143,C07D487/08,C07D498/04,101,C07D513/04,301

Stage: Grant (IP right granted...